Generics companies get green light for Lundbeck drug
![Photo: Jens Dresling](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article12777507.ece/ALTERNATES/schema-16_9/doc7emdgwotu8kk14wpki5.jpg)
On Feb. 18, the patent for Lundbeck's Northera officially expired in the US, after which companies are lining up to bite into the market, which the Danish pharmaceutical giant has exclusive rights to up until now.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Lundbeck hunts for new success drugs in niche diseases
For subscribers